FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018635983> ?p ?o ?g. }

• W2018635983 endingPage "551" @default.
• W2018635983 startingPage "544" @default.
• W2018635983 abstract "Measles virus Edmonston strain (MV-Edm) is thought to have remarkable oncolytic activity that selectively destroys human tumor cells. The P/V/C protein of wild-type MV was shown to resist the antiviral effects of interferon (IFN)-α. Here, we engineered new MVs by arming MV-Edm tag strain (a V-defective vaccine-lineage strain, MV-Etag) with the P or N, P, and L genes of wild-type MV (MV-P and MV-NPL, respectively). The oncolytic activities of the MVs were determined in human renal cell carcinoma (RCC) cell lines and primary human RCC cells by the MTT assay. The antitumor efficacy of the MVs was evaluated in A-498 xenografts in nude mice. IFN-α effectively inhibited the replication of MV-Etag and MV-P, but not MV-NPL. MV-NPL more efficiently induced cytopathic effects (CPEs) in OS-RC-2 cells, even in the presence of human IFN-α. MV-NPL replicated more rapidly than MV-P and MV-Etag in A-498 cells. Apoptosis was induced earlier in A-498 cells by MV-NPL than MV-Etag and MV-P. MV-NPL showed more significant antitumoral effects and had prolonged replication compared to MV-Etag and MV-P. In this study, we demonstrated that the newly engineered MV-NPL has more effective oncolytic activity and may help establish an innovative cancer therapy. Measles virus Edmonston strain (MV-Edm) is thought to have remarkable oncolytic activity that selectively destroys human tumor cells. The P/V/C protein of wild-type MV was shown to resist the antiviral effects of interferon (IFN)-α. Here, we engineered new MVs by arming MV-Edm tag strain (a V-defective vaccine-lineage strain, MV-Etag) with the P or N, P, and L genes of wild-type MV (MV-P and MV-NPL, respectively). The oncolytic activities of the MVs were determined in human renal cell carcinoma (RCC) cell lines and primary human RCC cells by the MTT assay. The antitumor efficacy of the MVs was evaluated in A-498 xenografts in nude mice. IFN-α effectively inhibited the replication of MV-Etag and MV-P, but not MV-NPL. MV-NPL more efficiently induced cytopathic effects (CPEs) in OS-RC-2 cells, even in the presence of human IFN-α. MV-NPL replicated more rapidly than MV-P and MV-Etag in A-498 cells. Apoptosis was induced earlier in A-498 cells by MV-NPL than MV-Etag and MV-P. MV-NPL showed more significant antitumoral effects and had prolonged replication compared to MV-Etag and MV-P. In this study, we demonstrated that the newly engineered MV-NPL has more effective oncolytic activity and may help establish an innovative cancer therapy." @default.
• W2018635983 created "2016-06-24" @default.
• W2018635983 creator A5000508958 @default.
• W2018635983 creator A5002399900 @default.
• W2018635983 creator A5017716828 @default.
• W2018635983 creator A5032570626 @default.
• W2018635983 creator A5034730667 @default.
• W2018635983 creator A5039422869 @default.
• W2018635983 creator A5068560615 @default.
• W2018635983 creator A5071254876 @default.
• W2018635983 creator A5073496264 @default.
• W2018635983 creator A5078039491 @default.
• W2018635983 creator A5078437261 @default.
• W2018635983 creator A5085420437 @default.
• W2018635983 date "2010-03-01" @default.
• W2018635983 modified "2023-10-16" @default.
• W2018635983 title "Enhanced Antitumor Effects of an Engineered Measles Virus Edmonston Strain Expressing the Wild-type N, P, L Genes on Human Renal Cell Carcinoma" @default.
• W2018635983 cites W1542841931 @default.
• W2018635983 cites W1591890160 @default.
• W2018635983 cites W1845094941 @default.
• W2018635983 cites W1968898334 @default.
• W2018635983 cites W1971042261 @default.
• W2018635983 cites W1972455109 @default.
• W2018635983 cites W1976892064 @default.
• W2018635983 cites W1980717355 @default.
• W2018635983 cites W1993168301 @default.
• W2018635983 cites W1995751033 @default.
• W2018635983 cites W2028074588 @default.
• W2018635983 cites W2034251241 @default.
• W2018635983 cites W2038237282 @default.
• W2018635983 cites W2042288895 @default.
• W2018635983 cites W2043083527 @default.
• W2018635983 cites W2043746453 @default.
• W2018635983 cites W2050869900 @default.
• W2018635983 cites W2050963689 @default.
• W2018635983 cites W2053466821 @default.
• W2018635983 cites W2068046268 @default.
• W2018635983 cites W2069733047 @default.
• W2018635983 cites W2074850109 @default.
• W2018635983 cites W2076429505 @default.
• W2018635983 cites W2079647238 @default.
• W2018635983 cites W2092333125 @default.
• W2018635983 cites W2092352693 @default.
• W2018635983 cites W2093114761 @default.
• W2018635983 cites W2093780636 @default.
• W2018635983 cites W2102769295 @default.
• W2018635983 cites W2102883003 @default.
• W2018635983 cites W2103256609 @default.
• W2018635983 cites W2110410873 @default.
• W2018635983 cites W2128131213 @default.
• W2018635983 cites W2139713123 @default.
• W2018635983 cites W2140542285 @default.
• W2018635983 cites W2154781639 @default.
• W2018635983 cites W2161051851 @default.
• W2018635983 cites W2167918826 @default.
• W2018635983 cites W2169788601 @default.
• W2018635983 cites W76787895 @default.
• W2018635983 doi "https://doi.org/10.1038/mt.2009.296" @default.
• W2018635983 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2839424" @default.
• W2018635983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20051938" @default.
• W2018635983 hasPublicationYear "2010" @default.
• W2018635983 type Work @default.
• W2018635983 sameAs 2018635983 @default.
• W2018635983 citedByCount "30" @default.
• W2018635983 countsByYear W20186359832012 @default.
• W2018635983 countsByYear W20186359832013 @default.
• W2018635983 countsByYear W20186359832014 @default.
• W2018635983 countsByYear W20186359832015 @default.
• W2018635983 countsByYear W20186359832016 @default.
• W2018635983 countsByYear W20186359832017 @default.
• W2018635983 countsByYear W20186359832018 @default.
• W2018635983 countsByYear W20186359832019 @default.
• W2018635983 countsByYear W20186359832020 @default.
• W2018635983 countsByYear W20186359832021 @default.
• W2018635983 countsByYear W20186359832022 @default.
• W2018635983 countsByYear W20186359832023 @default.
• W2018635983 crossrefType "journal-article" @default.
• W2018635983 hasAuthorship W2018635983A5000508958 @default.
• W2018635983 hasAuthorship W2018635983A5002399900 @default.
• W2018635983 hasAuthorship W2018635983A5017716828 @default.
• W2018635983 hasAuthorship W2018635983A5032570626 @default.
• W2018635983 hasAuthorship W2018635983A5034730667 @default.
• W2018635983 hasAuthorship W2018635983A5039422869 @default.
• W2018635983 hasAuthorship W2018635983A5068560615 @default.
• W2018635983 hasAuthorship W2018635983A5071254876 @default.
• W2018635983 hasAuthorship W2018635983A5073496264 @default.
• W2018635983 hasAuthorship W2018635983A5078039491 @default.
• W2018635983 hasAuthorship W2018635983A5078437261 @default.
• W2018635983 hasAuthorship W2018635983A5085420437 @default.
• W2018635983 hasBestOaLocation W20186359831 @default.
• W2018635983 hasConcept C104317684 @default.
• W2018635983 hasConcept C143065580 @default.
• W2018635983 hasConcept C153911025 @default.
• W2018635983 hasConcept C159047783 @default.
• W2018635983 hasConcept C190283241 @default.
• W2018635983 hasConcept C207583985 @default.
• W2018635983 hasConcept C22070199 @default.
• W2018635983 hasConcept C2522874641 @default.

• next